Definitive Healthcare Corp. (DH)

NASDAQ: DH · Real-Time Price · USD
4.100
-0.080 (-1.91%)
Nov 20, 2024, 4:00 PM EST - Market closed
-1.91%
Market Cap 635.16M
Revenue (ttm) 255.85M
Net Income (ttm) -364.28M
Shares Out 154.92M
EPS (ttm) -3.11
PE Ratio n/a
Forward PE 13.87
Dividend n/a
Ex-Dividend Date n/a
Volume 211,459
Open 4.170
Previous Close 4.180
Day's Range 4.064 - 4.190
52-Week Range 3.190 - 10.620
Beta 1.33
Analysts Hold
Price Target 6.28 (+53.17%)
Earnings Date Nov 7, 2024

About DH

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician... [Read more]

Sector Healthcare
IPO Date Sep 15, 2021
Employees 950
Stock Exchange NASDAQ
Ticker Symbol DH
Full Company Profile

Financial Performance

In 2023, Definitive Healthcare's revenue was $251.42 million, an increase of 12.92% compared to the previous year's $222.65 million. Losses were -$202.39 million, 2702.4% more than in 2022.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for DH stock is "Hold." The 12-month stock price forecast is $6.28, which is an increase of 53.17% from the latest price.

Price Target
$6.28
(53.17% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Definitive Healthcare Corp. (DH)) Q3 2024 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Richa...

10 days ago - Seeking Alpha

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024

Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase ...

13 days ago - GlobeNewsWire

Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations

Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement Monocl Conferences equips life science organizations with an intuitive...

4 weeks ago - GlobeNewsWire

Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions

Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities Market Forecast equips providers ...

5 weeks ago - GlobeNewsWire

Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp

On September 30, 2024, Irenic Capital Management LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 6,413,185 shares of Definitive Healthcare Corp (DH, Financi...

6 weeks ago - GuruFocus

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Definitive Health...

2 months ago - Business Wire

Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...

2 months ago - GlobeNewsWire

The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) on behalf of investors ...

3 months ago - Business Wire

Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion

Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights Population Intelligence empowers businesses ...

3 months ago - GlobeNewsWire

Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things

DH remains a hold rating due to its poor near-term outlook and recent results. 2Q24 results show decelerating growth, client count decline, and an elongated sales cycle. New CEO Kevin Coop could be a ...

3 months ago - Seeking Alpha

Definitive Healthcare Corp. (DH) Q2 2024 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Bo...

3 months ago - Seeking Alpha

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024

FRAMINGHAM, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, toda...

3 months ago - GlobeNewsWire

Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...

4 months ago - GlobeNewsWire

Baker Tilly and Definitive Healthcare enhance life sciences compliance

CHICAGO--(BUSINESS WIRE)--Leading advisory, tax and assurance firm Baker Tilly announces its collaboration with Definitive Healthcare to streamline fair market value (FMV) and key opinion leader (KOL)...

4 months ago - Business Wire

Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence

DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices DH View Suite gives sales and marketing teams instant access to critical intellige...

4 months ago - GlobeNewsWire

Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare's Board of...

5 months ago - GlobeNewsWire

Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award

Empowering healthcare and life science organizations with faster insights through seamless data sharing Empowering healthcare and life science organizations with faster insights through seamless data ...

5 months ago - GlobeNewsWire

Definitive Healthcare Publishes 2023 Sustainability Report

FRAMINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today released its 2023 sustainability report.

6 months ago - GlobeNewsWire

Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference

FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that i...

6 months ago - GlobeNewsWire

Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth

Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise

6 months ago - GlobeNewsWire

Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference

FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that i...

6 months ago - GlobeNewsWire

Definitive Healthcare Corp. (DH) Q1 2024 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Jason Krantz - Founder, Executive Chairman a...

6 months ago - Seeking Alpha

Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that...

7 months ago - GlobeNewsWire

VML and Definitive Healthcare announce partnership to transform key opinion leader management

Partnership offers solution to streamline engagement between pharmaceutical companies and KOLs to help increase the value of the clinical collaborations and conversations Partnership offers solution t...

8 months ago - GlobeNewsWire

Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25

Definitive Healthcare stock is recommended as a buy due to strong long-term growth prospects and potential for margin expansion. Recent results show revenue growth in line with estimates and improved ...

8 months ago - Seeking Alpha